Rob Sabo

Author
Rob Sabo has worked as a business journalist for nearly two decades and covers a broad range of business topics for The Epoch Times.

LATEST

Faced With Collections, Borrowers May Prioritize Delinquent Student Loan Repayment: Survey

Faced With Collections, Borrowers May Prioritize Delinquent Student Loan Repayment: Survey

Oracle Promotes 2 Longtime Insiders as Co-CEOs to Drive Cloud and AI Growth

Oracle Promotes 2 Longtime Insiders as Co-CEOs to Drive Cloud and AI Growth

Gen Z Students Leading Wave of Enrollment in Trade Schools: Market Report

Gen Z Students Leading Wave of Enrollment in Trade Schools: Market Report

Waymo Partners With Via to Add Robotaxis to Phoenix Suburb’s Public Transit

Waymo Partners With Via to Add Robotaxis to Phoenix Suburb’s Public Transit

BWXT Wins $1.5 Billion DOE Contract to Resume Domestic Uranium Enrichment

BWXT Wins $1.5 Billion DOE Contract to Resume Domestic Uranium Enrichment

US Credit Scores Dip as Loan Delinquencies Rise

US Credit Scores Dip as Loan Delinquencies Rise

Eli Lilly Plans $5 Billion Virginia Facility to Expand US Drug Production

Eli Lilly Plans $5 Billion Virginia Facility to Expand US Drug Production

Faced With Collections, Borrowers May Prioritize Delinquent Student Loan Repayment: Survey

Faced With Collections, Borrowers May Prioritize Delinquent Student Loan Repayment: Survey

Oracle Promotes 2 Longtime Insiders as Co-CEOs to Drive Cloud and AI Growth

Oracle Promotes 2 Longtime Insiders as Co-CEOs to Drive Cloud and AI Growth

Gen Z Students Leading Wave of Enrollment in Trade Schools: Market Report

Gen Z Students Leading Wave of Enrollment in Trade Schools: Market Report

Waymo Partners With Via to Add Robotaxis to Phoenix Suburb’s Public Transit

Waymo Partners With Via to Add Robotaxis to Phoenix Suburb’s Public Transit

BWXT Wins $1.5 Billion DOE Contract to Resume Domestic Uranium Enrichment

BWXT Wins $1.5 Billion DOE Contract to Resume Domestic Uranium Enrichment

US Credit Scores Dip as Loan Delinquencies Rise

US Credit Scores Dip as Loan Delinquencies Rise

Eli Lilly Plans $5 Billion Virginia Facility to Expand US Drug Production

Eli Lilly Plans $5 Billion Virginia Facility to Expand US Drug Production